Cleared Traditional

K222065 - Passeo-35 Xeo Peripheral Dilatation Catheter

K222065 is an FDA 510(k) clearance for Passeo-35 Xeo Peripheral Dilatation Cat..., manufactured by Biotronik, Inc.. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 218-day FDA review.

K222065 · Biotronik, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
218d
Days
Class 2
Risk

K222065 is an FDA 510(k) clearance for the Passeo-35 Xeo Peripheral Dilatation Catheter. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Biotronik, Inc. (Lake Oswego, US). The FDA issued a Cleared decision on February 16, 2023 after a review of 218 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biotronik, Inc. devices

FDA 510(k) Submission Details - K222065

510(k) Number K222065 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2022
Decision Date February 16, 2023
Days to Decision 218 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d slower than avg
Panel avg: 125d · This submission: 218d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 344
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K222065.
Finesse™ Injectable PTA Balloon Dilatation Catheter
K230263 · Summa Therapeutics, LLC · May 2023
D·Kaptain PTA High Pressure Balloon Dilatation Catheter
K214009 · Dk Medical Technology Co., Ltd. · Apr 2023
Arise™ UHP Dilatation Catheter
K230191 · Creagh Medical, Ltd. · Mar 2023
Highlander™ 014 PTA Balloon Dilatation Catheter
K223177 · C.R. Bard, Inc. · Jan 2023
PTA Balloon Dilatation Catheter
K221245 · Kossel Medtech (Suzhou) Co., Ltd. · Dec 2022
ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter
K221414 · Silk Road Medical, Inc. · Sep 2022